Li Lan, MD, PhD, researches how cancer cells respond to DNA damage through DNA repair mechanisms. The major focus of her lab — previously situated at The Krantz Family Center for Cancer Research, Mass General Cancer Center — is drug development.

Eleanor Scott Bell, 79, was born and raised in Lumberton, the capital of Robeson County in North Carolina. One of her earliest memories is of picking tobacco to supplement the family income. They were a family of nine with a large extended family.

Omidubicel, a novel cellular therapy, expands the availability of donor stem cell transplants to more patients.

Data at Their Digital Fingertips: Precision Cancer Medicine & Tissue-Based Research Comes of Age

From the 1970s through the 2020s, here are the milestones achieved at the Duke Division of Gynecologic Oncology over the past 50 years.

In 1972, William T. Creasman, MD, established the Division of Gynecologic Oncology in the Department of Obstetrics and Gynecology at Duke, becoming the division’s first chief. The rest is history.

For the first time since 2019, the DCI Scientific Retreat was held in person with a full program followed by a poster session and mingling — attracted around 90 faculty, staff, and trainees.

(Clinical Practice Today is a publication targeted at Duke Health Referring Physicians)

Includes: "Data at their Digital Fingertips:Tissue-Based Research & Precision Cancer Medicine Come of Age;""A Seismic Shift:Expanding the Reach of Precision Cancer Medicine;" "Partners to the Core;""Duke Expands Footprint in Next Gen Cancer Medicine"

Learn how Duke/DCI is expanding its footprint in next generation cancer sequencing tech via the Clinical Molecular Diagnostics Laboratory.

Learn how the Precision Cancer Medicine Initiative, run jointly by DCI and the Duke Dept. of Pathology, is advancing research, extending lives, and breaking down barriers to access.

The Duke BioRepository & Precision Pathology Center grew, thrived, and progressively built a national reputation. “Its success represents the evolution and extension of the Department of Pathology’s support and commitment to cancer research."

Tissue-Based Research & Precision Cancer Medicine Come of Age: A Special Report by Duke Cancer Institute & the Department of Pathology, Duke University School of Medicine — as featured in the 2021-22 Department of Pathology Annual Report.

[Duke Pathology website version] Tissue-Based Research & Precision Cancer Medicine Come of Age: A Special Report by Duke Cancer Institute & the Department of Pathology, Duke University School of Medicine

The Duke BioRepository & Precision Pathology Center commemorates 10 years of service. (2012-2022)

Flags were lowered to half-staff today (June 17, 2020) across Duke for Neil Spector, MD, a nationally recognized physician-scientist, translational research leader, and oncology mentor, who passed away on Sunday, June 14, 2020. He was 63.

The DCI 8th Annual Scientific Retreat attracted a broad array of faculty, trainees (students, residents, fellows, postdocs, etc.) and staff. For a second year, the retreat was entirely virtual.

A large group of DCI investigators led by Gayathri Devi, PhD, has been awarded a three-year $1.6 million U.S. Department of Defense grant for investigating the mechanisms underlying inflammatory breast cancer metastasis.

These distinguished awards support oncology trainees "for their respective field and research advancements within the cancer care community " and who are first authors on abstracts selected for presentation at the ASCO Annual Meeting.